Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Craig A. Elmets.
NEJM Journal Watch | 2009
Craig A. Elmets
The possibility that nonmelanoma skin cancers might be prevented by use of topical and systemic retinoids has long been of interest, although few data are available on use in patients with extensive actinic damage. Recently, investigators conducted a placebo-controlled, double-blind, multicenter clinical trial to evaluate the efficacy and safety of 0.1% tretinoin cream in subjects at risk for nonmelanoma skin cancers. Sponsored by the U.S. Department of Veterans Affairs, the study enrolled 1131 veterans at six sites …
NEJM Journal Watch | 2009
Craig A. Elmets
The International Agency for Research on Cancer (IARC) is a section of the World Health Organization whose mission is to develop strategies for cancer
NEJM Journal Watch | 2006
Craig A. Elmets
For decades, solar radiation in the UVB spectrum (290 nm–320 nm) has been recognized as the primary etiologic agent of nonmelanoma skin cancer. Cyclobutane pyrimidine dimers (CPDs) develop in skin exposed to UVB and produce genetic alterations in DNA that cause cutaneous squamous cell and basal cell carcinomas. The increasing use of UVA tanning beds and the unclear role of specific UV wavelengths in the development …
NEJM Journal Watch | 2016
Craig A. Elmets
When interleukin (IL)-12, IL-23, IL-22, IL-17, IL-6, IFN-γ, and type I interferons bind to their receptors, JAK1 and JAK2 proteins are activated,
NEJM Journal Watch | 2016
Craig A. Elmets
Sponsoring Organization: U.S. Preventive Services Task Force (USPSTF) Target Audience: Dermatologists, primary clinicians Background and Objective In an effort to limit the number of new melanomas, adults are encouraged to undergo periodic visual screenings by physicians, as part of their preventive healthcare regimen. The USPSTF has examined the available evidence and prepared this draft evidence review, with a focus on asymptomatic adults without history of skin cancer. Limitations Only two studies were identified, neither of which was a randomized, controlled trial. One examined the effects of regular screening exams on the reduction in melanoma deaths, and the other …
NEJM Journal Watch | 2015
Craig A. Elmets
Vitiligo is a depigmenting condition that affects 0.5% to 1.0% of individuals. It can have devastating emotional effects on afflicted patients. The
NEJM Journal Watch | 2015
Craig A. Elmets
Treatment options for moderate to severe psoriasis usually require systemic medications. Although a number of reports evaluate the safety, efficacy,
NEJM Journal Watch | 2015
Craig A. Elmets
The FDA recently reclassified indoor tanning devices that emit ultraviolet (UV) radiation from low risk (class I) to moderate risk (class II). This action was prompted primarily by data showing that indoor tanning bed use is linked to both melanoma and nonmelanoma skin cancers. Tanning bed use can also result in acute adverse effects, but little information has been published on such incidence. In …
NEJM Journal Watch | 2015
Craig A. Elmets
Recipients of some (e.g., cyclosporine, azathioprine) but not all (systemic corticosteroids) forms of immunosuppression increase risk for developing
NEJM Journal Watch | 2015
Physician's First Watch Amy Orciari Herman; Craig A. Elmets
Nicotinamide (a form of vitamin B3) reduces the incidence of nonmelanoma skin cancers (NMSCs) in high-risk adults, according to study results released